OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001764013

Immunovant, Inc. (IMVT)

Immunovant, Inc. (CIK 0001764013, ticker IMVT, EIN 83-2771572) reported net income of -$505.61 million (-$505,606,000) for FY2026 (2025-04-01 to 2026-03-31) and total assets of $957.01 million ($957,014,000) for FY2026 (as of 2026-03-31), as filed in its 10-K filed 2026-05-20 (accession 0001764013-26-000064).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends March 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001764013
TickersIMVT (Nasdaq)
EIN83-2771572
SIC industry code2836 Biological Products, (No Diagnostic Substances)
State or country of incorporationDE
Fiscal year endMarch 31
Filer categoryLarge accelerated filer
Entity typeoperating
Olympus entity IDorg_2q90a3np2tp520pcjkx24ceawe
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Net income-$505,606,000FY20262025-04-01 to 2026-03-3110-K2026-05-200001764013-26-000064NetIncomeLoss
Total assets$957,014,000FY2026as of 2026-03-3110-K2026-05-200001764013-26-000064Assets
Total liabilities$104,422,000FY2026as of 2026-03-3110-K2026-05-200001764013-26-000064Liabilities
Stockholders' equity$852,592,000FY2026as of 2026-03-3110-K2026-05-200001764013-26-000064StockholdersEquity
Operating cash flow-$407,310,000FY20262025-04-01 to 2026-03-3110-K2026-05-200001764013-26-000064NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$2.77 per shareFY20262025-04-01 to 2026-03-3110-K2026-05-200001764013-26-000064EarningsPerShareDiluted
Shares outstanding205,308,917 sharesFY2026as of 2026-05-1410-K2026-05-200001764013-26-000064EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2017-2026, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
Net incomeFY20262025-04-01 to 2026-03-31-$505,606,00010-K2026-05-200001764013-26-000064
Net incomeFY20252024-04-01 to 2025-03-31-$413,840,00010-K2026-05-200001764013-26-000064
Net incomeFY20242023-04-01 to 2024-03-31-$259,336,00010-K2026-05-200001764013-26-000064
Net incomeFY20232022-04-01 to 2023-03-31-$210,960,00010-K2025-05-290001764013-25-000092
Net incomeFY20222021-04-01 to 2022-03-31-$156,730,00010-K2023-05-220001764013-23-000065
Net incomeFY20202020-04-01 to 2021-03-31-$107,431,00010-K2022-06-080001764013-22-000059
Net incomeFY20192019-04-01 to 2020-03-31-$66,388,00010-K2021-06-010001764013-21-000052

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2026-08-062026-06-300001764013-26-000101imvt-20260630.htm
10-K2026-05-202026-03-310001764013-26-000064imvt-20260331.htm
10-Q2026-02-062025-12-310001764013-26-000011imvt-20251231.htm
10-Q2025-11-102025-09-300001764013-25-000149imvt-20250930.htm
10-Q2025-08-112025-06-300001764013-25-000129imvt-20250630.htm
10-K2025-05-292025-03-310001764013-25-000092imvt-20250331.htm
10-Q2025-02-062024-12-310001764013-25-000026imvt-20241231.htm
10-Q2024-11-072024-09-300001764013-24-000184imvt-20240930.htm
10-Q2024-08-062024-06-300001764013-24-000148imvt-20240630.htm
10-K2024-05-292024-03-310001764013-24-000109imvt-20240331.htm
10-Q2024-02-122023-12-310001764013-24-000026imvt-20231231.htm
10-Q2023-11-092023-09-300001764013-23-000133imvt-20230930.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001764013published by the sourcedata.sec.gov/submissions/CIK0001764013.json2026-10-21
Employer Identification Number (EIN) · US-EIN83-2771572published by the sourcedata.sec.gov/submissions/CIK0001764013.json2026-10-21

Former names

NameFromTo
Health Sciences Acquisitions Corp2019-01-232019-12-20

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001764013.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001764013.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001764013" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001764013/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001764013/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1764013"}

On SEC EDGAR

About this data